ICE (Ifosfamide, Carboplatin, Etoposide) Chemotherapy and Systemic Hyperthermia

Publisher： Karger

E-ISSN： 2296-5262|21|2|10-11

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.2, 1998-06, pp. : 10-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Risk-Adapted Chemotherapy of Germ Cell Tumors with Carboplatin, Etoposide and Bleomycin for Low-Risk and Cisplatin, Etoposide and Ifosfamide for High-Risk Patients

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 110-117

Karger

Access to resources Recommend Favorite

Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 330-332

Karger

Access to resources Recommend Favorite

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

Early Tandem High-Dose Ifosfamide, Carboplatin, Etoposide Therapy with Stem Cell Rescue for Small-Cell Lung Cancer: Brief Report on the Results of a Phase-I/II Trial

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 248-253

Karger

Access to resources Recommend Favorite